Clinical Advances in Myelofibrosis From EHA 2023.

Published Date: 01 Jul 2023

Myelofibrosis updates from EHA 2023 cover novel approaches in ruxolitinib-resistant patients, use of BET inhibitors plus JAK inhibitors to deepen response, and luspatercept to treat anemia.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Common intracellular toxin could help fight leukemia

2.

CAR T-Cell Therapy Shows Promise in Mantle Cell Lymphoma

3.

Scholastic performance is a key concern for young cancer patients, study finds

4.

AACR: American Association for Cancer Research

5.

Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot